• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度一家三级眼科保健机构收治的 1000 例甲状腺眼病患者的人口统计学和临床特征。

Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India.

机构信息

Ophthalmic Plastic Surgery Service, L.V. Prasad Eye Institute, Hyderabad, India.

出版信息

Int Ophthalmol. 2021 Jan;41(1):231-236. doi: 10.1007/s10792-020-01571-6. Epub 2020 Aug 25.

DOI:10.1007/s10792-020-01571-6
PMID:32844239
Abstract

PURPOSE

To assess the demographic and clinical profile of thyroid eye disease (TED) presenting to a Tertiary Eye Care Institute in India.

METHODS

All patients who were diagnosed to have TED between the year 2007 and 2017 at the Ophthalmic Plastic Surgery Service, LV Prasad Eye Institute, were included in this retrospective observational study. The demographic details of parameters such as age, gender and laterality, presenting signs and symptoms, clinical activity at presentation, and systemic thyroid status were assessed.

RESULTS

A total of 1000 consecutive patients of TED were evaluated in the 10-year period. Average age at presentation was 44.9 years (range 8-89). Of the 1000, 529 (53%) were males, and 358 (36%) had unilateral TED. At presentation, the TED was active (time since onset ≤ 12 months) in 476 (48%) cases and 71 (7%) had dysthyroid optic neuropathy. Of the 913 patients where systemic thyroid status was available at the time of presentation, 342 (37%) were euthyroid at presentation. Of the patients who were active at presentation (n = 476), 349 (70.3%) were 'Silent presenters' (Active as per timeline, but CAS ≤ 3). A prominent eye was the most common presenting symptom in 563 (64%) patients. Presenting signs in order of frequency were proptosis in 582 (58%), lower lid retraction (49%), upper lid retraction (48%), strabismus (6%), ptosis (5.5%), and corneal ulcer (1.3%).

CONCLUSIONS

TED in India presents to the tertiary eye center with slight male preponderance. One-third (37%) are euthyroid and half (48%) are active at presentation. One-third (35%) are silent presenters, with minimal clinical activity during the active phase of TED.

摘要

目的

评估在印度一家三级眼科保健机构就诊的甲状腺眼病(TED)患者的人口统计学和临床特征。

方法

本回顾性观察研究纳入了 2007 年至 2017 年期间在 LV 普拉萨德眼科研究所眼科整形手术服务部被诊断为 TED 的所有患者。评估了年龄、性别和侧别、就诊时的体征和症状、就诊时的临床活动以及全身甲状腺状态等参数的人口统计学细节。

结果

在 10 年期间,共评估了 1000 例连续 TED 患者。就诊时的平均年龄为 44.9 岁(范围 8-89 岁)。在 1000 例患者中,529 例(53%)为男性,358 例(36%)为单侧 TED。就诊时,476 例(48%)的 TED 处于活动期(发病时间≤12 个月),71 例(7%)患有甲状腺毒性视神经病变。在就诊时可获得全身甲状腺功能状态的 913 例患者中,342 例(37%)就诊时处于甲状腺功能正常状态。在就诊时处于活动期的患者中(n=476),349 例(70.3%)为“无症状患者”(根据时间线为活动期,但 CAS≤3)。突出的眼睛是 563 例(64%)患者最常见的就诊症状。按频率顺序排列的就诊体征是眼球突出 582 例(58%)、下眼睑退缩 49%、上眼睑退缩 48%、斜视 6%、上睑下垂 5.5%和角膜溃疡 1.3%。

结论

印度的 TED 患者就诊于三级眼科中心,男性略占优势。三分之一(37%)为甲状腺功能正常,一半(48%)就诊时处于活动期。三分之一(35%)为无症状患者,在 TED 的活动期,其临床活动最小。

相似文献

1
Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India.印度一家三级眼科保健机构收治的 1000 例甲状腺眼病患者的人口统计学和临床特征。
Int Ophthalmol. 2021 Jan;41(1):231-236. doi: 10.1007/s10792-020-01571-6. Epub 2020 Aug 25.
2
A retrospective study of pediatric thyroid eye disease: the Asian experience.回顾性研究儿科甲状腺眼病:亚洲经验。
Orbit. 2022 Feb;41(1):69-78. doi: 10.1080/01676830.2020.1831550. Epub 2020 Oct 15.
3
Microbial Keratitis in Thyroid Eye Disease: Clinical Features, Microbiological Profile, and Treatment Outcome.甲状腺眼病相关性微生物角膜炎:临床特征、微生物特征及治疗结局。
Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):543-548. doi: 10.1097/IOP.0000000000001361.
4
Blepharoptosis in thyroid eye disease: etiopathogenesis, clinical features and correlation with thyroid eye disease.甲状腺相关眼病中的上睑下垂:发病机制、临床特征及与甲状腺眼病的相关性。
Int Ophthalmol. 2022 Jan;42(1):13-18. doi: 10.1007/s10792-021-01992-x. Epub 2021 Aug 4.
5
Clinical profile of 80-year-old and older thyroid eye disease patients.80岁及以上甲状腺眼病患者的临床特征
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2727-2736. doi: 10.1007/s00417-022-05627-4. Epub 2022 Mar 26.
6
Thyroid eye disease: a Southeast Asian experience.甲状腺眼病:东南亚地区的经验
Br J Ophthalmol. 2015 Apr;99(4):512-8. doi: 10.1136/bjophthalmol-2014-305649. Epub 2014 Oct 31.
7
Thyroid eye disease presenting with superior rectus/levator complex enlargement.表现为上直肌/提上睑肌复合体增大的甲状腺眼病。
Orbit. 2020 Feb;39(1):5-12. doi: 10.1080/01676830.2019.1594969. Epub 2019 May 6.
8
Expanding Understanding of Thyroid Eye Disease Manifestations to Include Hispanic and Black Patients.扩大对甲状腺眼病表现的认识,纳入西班牙裔和非裔患者。
Middle East Afr J Ophthalmol. 2023 Nov 21;29(4):171-180. doi: 10.4103/meajo.meajo_87_23. eCollection 2022 Oct-Dec.
9
The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.安静型甲状腺眼病——甲状腺眼病的一个特殊亚群。
Ophthalmic Plast Reconstr Surg. 2021;37(6):551-555. doi: 10.1097/IOP.0000000000001942.
10
Age differences in clinical manifestation and prognosis of thyroid eye disease.甲状腺眼病临床表现及预后的年龄差异
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2301-8. doi: 10.1007/s00417-015-3156-2. Epub 2015 Sep 7.

引用本文的文献

1
Study on the correlation between serum IgG4/IgG levels and the development of Graves' ophthalmopathy.血清IgG4/IgG水平与Graves眼病发生发展的相关性研究
Sci Rep. 2025 Jan 22;15(1):2770. doi: 10.1038/s41598-025-87126-0.
2
Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients.年龄和性别对甲状腺相关眼病临床表现的影响:2479 例中国患者的病例系列研究。
Front Endocrinol (Lausanne). 2024 Oct 3;15:1434155. doi: 10.3389/fendo.2024.1434155. eCollection 2024.
3
Assessment of choroidal perfusion indices in thyroid eye disease by using optical coherence tomography.

本文引用的文献

1
Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.在印度北部一家转诊中心就诊的格雷夫斯病患者中格雷夫斯眼病的患病率。
Indian J Med Res. 2014 Jan;139(1):99-104.
2
Graves' orbitopathy: Management of difficult cases.格雷夫斯眼眶病:疑难病例的管理
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S150-2. doi: 10.4103/2230-8210.104026.
采用光学相干断层扫描评估甲状腺眼病的脉络膜灌注指数。
Indian J Ophthalmol. 2024 Nov 1;72(11):1639-1644. doi: 10.4103/IJO.IJO_3315_23. Epub 2024 May 20.
4
Alterations in retrobulbar haemodynamics in thyroid eye disease.甲状腺眼病的球后血液动力学改变。
Eye (Lond). 2023 Dec;37(17):3682-3690. doi: 10.1038/s41433-023-02580-2. Epub 2023 May 23.
5
Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.甲状腺眼病及其在 Academy IRIS 注册研究中的威胁视力表现:2014-2018 年。
Am J Ophthalmol. 2023 Sep;253:74-85. doi: 10.1016/j.ajo.2023.04.013. Epub 2023 May 17.
6
A comparison between bilateral and unilateral thyroid eye disease.双侧与单侧甲状腺眼病的比较。
Int Ophthalmol. 2023 Aug;43(8):2957-2962. doi: 10.1007/s10792-023-02702-5. Epub 2023 Apr 17.
7
Clinical characteristics and the treatment modalities of Graves' orbitopathy in a tertiary referral center in Turkey: changes over two decades.土耳其一家三级转诊中心Graves眼病的临床特征及治疗方式:二十年的变化
Int Ophthalmol. 2023 Feb;43(2):643-653. doi: 10.1007/s10792-022-02468-2. Epub 2022 Aug 28.
8
Noninflammatory thyroid eye disease in Indian subcontinent: Is it a departure from Rundle's curve?印度次大陆的非炎性甲状腺眼病:它是否偏离了伦德尔曲线?
Indian J Ophthalmol. 2022 May;70(5):1866-1867. doi: 10.4103/ijo.IJO_2680_21.
9
Risk Factors for Reoperation after Strabismus Surgery among Patients with Thyroid Eye Disease.甲状腺相关眼病患者斜视手术后再次手术的危险因素。
Am J Ophthalmol. 2022 Jun;238:10-15. doi: 10.1016/j.ajo.2021.11.022. Epub 2021 Nov 27.
10
Absent Bell's phenomenon in patients with thyroid eye disease.甲状腺眼病患者的 Bell 现象缺失。
BMC Ophthalmol. 2021 Oct 11;21(1):361. doi: 10.1186/s12886-021-02107-x.